Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 2

Recruiting

Conditions: Pancreatic Ductal Adenocarcinoma

Interventions: Drug: NALIRIFOX
Combination Product: AD-XRT and Capecitabine

First Posted Date: 2023-05-10

Last Posted Date: 2025-06-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT05851924

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Not Applicable

Recruiting

Conditions: Invasive Ductal Breast Carcinoma
Gastrointestinal Cancer
Lobular Breast Carcinoma
Gastrointestinal Squamous Cell Cancer
Metastatic Solid Tumor
Lobular Breast Carcinoma Stage IV
NSCLC
Gastrointestinal Adenocarcinoma
Bladder Cancer
Invasive Ductal Breast Carcinoma Stage IV

Interventions: Radiation: Stereotactic body radiotherapy
Radiation: Lattice Radiation Therapy

First Posted Date: 2023-05-01

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 26

Registration Number: NCT05837767

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, United States

and more 4 locations

A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)

Recruiting

Conditions: Oropharyngeal Cancer
HPV-Related Carcinoma
HPV Positive Oropharyngeal Squamous Cell Carcinoma

Interventions: Diagnostic Test: NavDx

First Posted Date: 2023-04-18

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 600

Registration Number: NCT05814549

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack, New York, United States

and more 4 locations

A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

Phase 2

Recruiting

Conditions: Breast Cancer
Cardiac Dysfunction

Interventions: Drug: Vericiguat
Other: Optimal medical therapy

First Posted Date: 2023-04-10

Last Posted Date: 2025-04-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT05806138

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer

Not Applicable

Recruiting

Conditions: Colon Cancer Screening

Interventions: Other: Colorectal Cancer (CRC) education alone
Other: FITx3 intervention and CRC education

First Posted Date: 2023-03-31

Last Posted Date: 2025-04-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 80

Registration Number: NCT05793593

Locations: 🇺🇸
Memoiral Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

and more 4 locations

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

Phase 2

Recruiting

Conditions: Gastrointestinal Cancer

Interventions: Behavioral: structured treadmill walking

First Posted Date: 2023-03-29

Last Posted Date: 2025-04-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 216

Registration Number: NCT05789485

Locations: 🇺🇸
Hartford Healthcare Alliance (Data Collection Only), Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 5 locations

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Phase 2

Recruiting

Conditions: Autoimmune Lymphoproliferative
Immune System Diseases
Primary Immune Regulatory Disorder

Interventions: Drug: Fludarabine and Dexamethasone
Drug: Emapalumab
Procedure: Stem Cell Transplant

First Posted Date: 2023-03-28

Last Posted Date: 2025-04-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 39

Registration Number: NCT05787574

Locations: 🇺🇸
Children's Hospital of Philadelphia (Data Collection Only), Philadelphia, Pennsylvania, United States
🇺🇸
Children's Healthcare of Atlanta (Data Collection Only), Atlanta, Georgia, United States
🇺🇸
University of California, San Francisco (Data collection only), San Francisco, California, United States

and more 8 locations

A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma

Phase 2

Terminated

Conditions: Mantle Cell Lymphoma
MCL

Interventions: Drug: Tafasitamab
Drug: Lenalidomide

First Posted Date: 2023-03-28

Last Posted Date: 2025-05-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT05788289

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All protocol activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

Phase 2

Recruiting

Conditions: Mesonephric Gynecologic Cancer

Interventions: Drug: Avutometinib (VS-6766)
Drug: Defactinib

First Posted Date: 2023-03-28

Last Posted Date: 2025-04-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT05787561

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Phase 2

Recruiting

Conditions: Survivors of Childhood Cancer
Alopecia

Interventions: Drug: Oral Minoxidil
Other: Placebo

First Posted Date: 2023-03-21

Last Posted Date: 2024-07-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT05778825

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy